Sripal Bangalore at [NYU Langone Health]

Sripal Bangalore, MD

  • Specialties: Interventional Cardiology, Cardiology
  • Languages: English, Hindi
  • Phone: 212-263-5656

About Me

Conditions and Treatments

critical limb ischemia, congestive heart failure (CHF), renal artery stenosis, carotid stenosis, chest pain, mitral regurgitation (MR), arterial occlusive disease, heart disease, acute coronary syndrome, abnormal heart rhythms, heart attack, angina, aortic valve insufficiency, aortic valve stenosis, inflammation of the heart valve, heart muscle disease, peripheral vascular disease (PVD), claudication, aortic valve disease, mitral valve stenosis, carotid artery disease, high blood pressure disorder, coronary heart disease, arteriosclerosis, cardiac catheterization
Show More Conditions

Credentials

Positions
  • Associate Professor, Department of Medicine
Board Certifications
  • American Board of Internal Medicine (Interventional Cardiology), 2009
  • American Board of Internal Medicine (Cardiovascular Disease), 2008
Education and Training
  • Fellowship, Peter Bent Brigham Hospital, Interventional Cardiology, 2010
  • Fellowship, St. Luke's-Roosevelt Hospital Center, Cardiovascular Med, 2008
  • MD from Bangalore University, 2000
Departments

Is this your profile?

Edit profile

Is this your profile?

Edit profile

Locations and Appointments

View Insurance Plans Accepted
  • Aetna
    • Aetna HMO
    • Aetna Medicare
    • Aetna POS
    • Aetna PPO/EPO
  • Affinity
    • Affinity
    • Affinity Exchange- Essential
  • Agewell
    • Agewell
  • Centerlight
    • Centerlight
  • Cigna
    • Cigna EPO/POS
    • Cigna PPO
  • ElderPlan
    • ElderPlan
  • Emblem
    • Emblem Select Care Exchange
  • Empire Blue Cross Blue Shield
    • Empire Blue Cross Blue Shield EPO
    • Empire Blue Cross Blue Shield HMO
    • Empire Blue Cross Blue Shield HealthPlus
    • Empire Blue Cross Blue Shield HealthPlus Essential
    • Empire Blue Cross Blue Shield Indemnity
    • Empire Blue Cross Blue Shield MediBlue
    • Empire Blue Cross Blue Shield POS
    • Empire Blue Cross Blue Shield PPO
    • Empire Blue Cross Blue Shield Pathways, Enhanced
  • Fidelis
    • Fidelis Child Health
    • Fidelis Essential
    • Fidelis Exchange
    • Fidelis Family Health
    • Fidelis Medicaid
    • Fidelis Medicare
  • GHI
    • GHI CBP
    • GHI HMO
  • HIP
    • HIP Access I
    • HIP Access II
    • HIP Child Health
    • HIP EPO/PPO
    • HIP Essential
    • HIP HMO
    • HIP Medicaid
    • HIP Medicare
    • HIP POS
  • HealthSmart
    • HealthSmart (WTC)
  • Healthfirst
    • Healthfirst
    • Healthfirst Essential
  • Hotel Trades
    • Hotel Trades
  • Humana
    • Humana Medicare
  • Local 1199
    • Local 1199 PPO
  • MagnaCare
    • MagnaCare PPO
  • Medicaid
    • NY Medicaid
  • Medicare
    • Medicare
  • MetroPlus
    • MetroPlus Child Health
    • MetroPlus Essential
    • MetroPlus Exchange Plans
    • MetroPlus Family Health
    • MetroPlus Medicaid
    • MetroPlus Medicare
  • MultiPlan/PHCS
    • MultiPlan/PHCS PPO
  • NYS
    • NYS Empire Plan
  • Oxford
    • Oxford Freedom
    • Oxford Liberty
    • Oxford Medicare
  • Senior Whole Health
    • Senior Whole Health
  • Tricare
    • Tricare
  • UHC
    • UnitedHealthcare Community & State Plan
    • UnitedHealthcare EPO
    • UnitedHealthcare HMO
    • UnitedHealthcare Medicare
    • UnitedHealthcare POS
    • UnitedHealthcare PPO
    • UnitedHealthcare Top Tier
  • UPN
    • UPN Elite
  • VNS
    • Visiting Nurse Service (VNS) Medicare
  • Village Caremax
    • Village Caremax
  • WellCare
    • WellCare Child Health
    • WellCare Family Health
    • WellCare Medicaid
    • WellCare Medicare
NYU Cardiac Catheterization Associates

550 1st Avenue, 14th Floor
New York, NY 10016

Research My Research

Research Summary
Dr. Bangalore is the PI of a multicenter, international, randomized controlled trial conducted to define the role of an invasive approach in patients with stable ischemic heart disease and substantial ischemia and chronic kidney disease (eGFR <30 or on dialysis). Patients with advanced CKD and moderate to severe ischemia on stress testing will be randomized to INV strategy of cath with optimal revascularization along with optimal medical therapy or to a CON strategy of optimal medical therapy alone with cath reserved for OMT failure. http://clinicaltrials.gov/ct2/show/NCT01985360

Publications

  • Blood pressure control and mortality in US- and foreign-born blacks in New York City

    Gyamfi, Joyce; Butler, Mark; Williams, Stephen K; Agyemang, Charles; Gyamfi, Lloyd; Seixas, Azizi; Zinsou, Grace Melinda; Bangalore, Sripal; Shah, Nirav R; Ogedegbe, Gbenga Gyamfi, Joyce; Butler, Mark; Williams, Stephen K; Agyemang, Charles; Gyamfi, Lloyd; Seixas, Azizi; Zinsou, Grace Melinda; Bangalore, Sripal; Shah, Nirav R; Ogedegbe, Gbenga
    Journal of clinical hypertension (1999). 2017 Jul 6. ?-?

  • Body-Weight Fluctuations and Outcomes in Coronary Disease [Letter]

    Bangalore, Sripal; Messerli, Franz H; Waters, David D Bangalore, Sripal; Messerli, Franz H; Waters, David D
    New England journal of medicine. 2017 Jul 06. 377 (1): 95-96

  • Are ACE inhibitors acceptable ingredients in polypills? [Letter]

    Messerli, Franz H; Bangalore, Sripal; Rimoldi, Stefano F; Gasowski, Jerzy; Nussberger, Juerg Messerli, Franz H; Bangalore, Sripal; Rimoldi, Stefano F; Gasowski, Jerzy; Nussberger, Juerg
    Lancet. 2017 Jul 01. 390 (10089): 26-26

Read All Publications (416)